CME
Monograph
MedImmune,
Inc.
This
CME program highlights a potential new use for immune globulins:
to reduce panel-reactive antibodies in patients whose high
antibody levels prevent them from receiving solid-organ
transplants.
In
conjunction with J.D. Salthouse Associates.
